search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Industry News Mergers & Aquisitions


LANXESS completes acquisition of Brazilian biocide manufacturer IPEL


LANXESS has completed the acquisition of Brazilian biocides manufacturer Itibanyl Produtos Especiais Ltda. (IPEL). Headquartered in Jarinu, São Paulo, IPEL is one of Brazil’s leading biocide manufacturers and generated sales in the lower double-digit million dollar range in 2018, with about 100 employees. IPEL generates the majority of its sales through biocides and speciality chemicals for the paints and coatings industry. The company’s product portfolio also includes preservatives and fungicides for process control in water treatment as well as active ingredients for disinfection and cleaning agents.


Gilead Sciences to acquire interest in Pionyr Immunotherapeutics


Gilead Sciences, Inc is to acquire a 49.9% equity interest in Pionyr Immunotherapeutics Inc for $275 million with an exclusive option to purchase the remainder of Pionyr, a privately held company developing first-in-class cancer immunotherapies. Under the agreement, Pionyr’s shareholders may receive up to an additional $1.47 billion in option exercise fees and future milestone payments. Pionyr’s Myeloid Tuning therapies have the potential to treat patients who currently do not benefit from checkpoint inhibitor therapies and the company’s PY314 and PY159 candidates have demonstrated preclinical efficacy, suggesting potential in solid tumours in combination with established anti-PD(L)-1 agents. Pionyr plans to file investigational new drug (IND) applications with the FDA for both candidates in the third quarter of this year. Pending Phase 1b results from either candidate, or sooner if Gilead chooses, Gilead can exercise its exclusive option to acquire the remainder of Pionyr.


KRAHN Chemie acquires Greek distributor


KRAHN Chemie GmbH has acquired a majority share of InterActive SA, headquartered in Athens, Greece. Through this strategic acquisition, the KRAHN Chemie Group has expanded its footprint not only in Europe but also to cover the Israeli market. InterActive SA was founded in 1990 and specializes in the distribution of lubricant additives in the Israeli, Greek and Cypriot markets, as well as scientific instruments for R&D and QC laboratories in the oil, pharma & chemical industries by representing international manufacturers.


Eppendorf acquires centrifuge business of Koki Holdings Co, Ltd


Eppendorf AG and Koki Holdings Co, Ltd, have reached an agreement that Eppendorf will acquire the Japanese company’s centrifuge business, including the premium himac brand. The acquisition marks a targeted step by Hamburg, Germany-based Eppendorf AG to expand its centrifuge business, solidifying its strong market position as one of the world’s leading makers of high-end centrifuges for the pharmaceutical and life science industries as well as for academic and commercial research. Koki Holdings said that it will focus on developing its position as a comprehensive provider of power tools aiming to become a leading global company through strategic investment, accelerated technology and product development. Koki Holdings Co, Ltd, develops and produces ultracentrifuges and floor- standing centrifuges under the brand name himac.


12


www.chemicalsknowledgehub.com


Catalent completes purchase of pharmaceutical packaging facility in Japan


Catalent has completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, Shiga Prefecture, Japan. Operating in partnership with the company’s existing Japanese clinical supply facility located in Kakegawa, the new 60,000-square- foot facility will provide customers with flexible clinical supply solutions, serving both local customers and global biotech and pharmaceutical companies. Catalent stated that the facility would play an important


role in its expanding Asia-Pacific network, working alongside two sites in China and one in Singapore to support customers’ clinical trials across the region. The facility will offer extensive clinical supply services including access to Catalent’s FastChain demand-led supply services, primary and secondary packaging capabilities, and a range of temperature options for storage and distribution, as well as clinical returns and destruction services.


SOCMA on-demand training for chemical operators


SOCMA, the Society of Chemical Manufacturers and Affiliates, reports that since its launch in January, 15 companies across 42 facilities have adopted its Chemical Operations Training Tool to train and refresh employees on standard operations and processes in chemical manufacturing and that SOCMA is now expanding this modernized training tool to non- member manufacturers. “SOCMA developed this comprehensive programme with on-demand training in mind,” said Joe


Dettinger, Senior Director, Compliance & Stewardship at SOCMA. “Having led EHS&S operations at a facility for many years, I understand the importance of thorough training and the need to safely onboard operators about the mechanics behind each process.”


Companies that have implemented the modernized platform found the tool to be an efficient resource for both in-person and remote training. Further information can be found at www.socma.org


Eastman partners with IMCD Group to expand EMEA speciality plastics distribution network


Eastman Chemical is expanding and reinforcing its strategic partnership with IMCD Group for the distribution of its speciality plastics. The company offers the world’s largest portfolio of thermoplastic polyester materials and IMCD will distribute these products over a wide range of markets and applications, including medical, consumer durables, cosmetics, personal care, and packaging, amongst others. Currently, IMCD distributes Eastman speciality plastics in Spain and Portugal and under the new distribution agreement, IMCD will


also start serving an expanded EMEA market comprised of more than 30 countries.


“IMCD is already a strategic partner in the distribution for various Eastman speciality materials, with demonstrated synergies and processes alignment,” said Eastman sales director Oliver Osborne. “We believe this expanded partnership will ensure a smooth transition for our speciality plastics customers whose distribution arrangements with incumbent distribution partners finish at the end of July.”


Summer 2020


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60